Please login to the form below

Not currently logged in
Email:
Password:

UK agrees comms strategy for potential flu pandemic

Publication draws lessons from 2009 swine flu pandemic

Influenza pandemic communications

The Department of Health (DH) has published a communication strategy to help guide the government's response to future flu pandemics.

The UK Pandemic Influenza Communications Strategy 2012 sets out a communications framework for the UK government in response to a potential outbreak.

A pandemic from a new influenza virus remains a potential risk for the UK, the DH said, adding that the Government intends to remain as prepared as possible.

“This strategy covers health-related communication in the stages leading up to a UK pandemic, during a pandemic itself, and during the recovery phase.

"It focuses on mainstream communications channels with targeted elements for specific audiences,” the DH said.

The document should be read alongside the UK Influenza Pandemic Preparedness Strategy, published in November 2012, and the Health and Social Care Influenza Pandemic Preparedness and Response Guidance for the health and social care community, published in April 2012.

The strategy, which was developed jointly and agreed with the Devolved Administrations of Scotland, Wales and Northern Ireland, follows lessons learned from the 2009 H1N1 swine flu pandemic, specifically the need to plan flexibly and proportionately for a variety of possible scenarios.

9th January 2013

From: Marketing, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics